Science Explorer Interactive view Map
Company · Boston · United States

Intarcia Therapeutics (United States)

intarcia.comROR OpenAlex
Research works
68
▲ 202% vs 2013–17
Citations
1.9k
28.0 per fractional work
Top-10% rate
16.1%
record average 16.5%
Open access
49%
world 28%

Not ranked overall: Intarcia Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.25× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.50× its world share, 9 worksBiochemistry, Geneti…Immunology and Microbiology: 11.62× its world share, 4 worksImmunology and Micro…Neuroscience: 0.72× its world share, 0 worksNeuroscienceChemistry: 0.31× its world share, 0 worksChemistryComputer Science: 0.12× its world share, 0 worksComputer ScienceEngineering: 0.44× its world share, 2 worksEngineeringEnvironmental Science: 0.35× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.39× its world share, 0 worksMaterials ScienceMathematics: 0.36× its world share, 0 worksMathematicsHealth Professions: 0.05× its world share, 0 worksHealth ProfessionsMedicine: 2.27× its world share, 13 worksMedicineNursing: 0.37× its world share, 0 worksNursingBusiness, Management and Accounting: 0.04× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.07× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.06× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 11.6×. Every wedge is a field page.

Which keywords describe research at Intarcia Therapeutics (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunity, Antigen Presentation, Cancer Immunotherapy, Immunotherapy, Innate Immunity, Cancer, Dendritic Cells and Tumor Antigen.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 35 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 35 words, with their numbers
  1. Immunity4▲ 30×5 topics
  2. Antigen Presentation3▲ 116×2 topics
  3. Cancer Immunotherapy3▲ 66×2 topics
  4. Immunotherapy3▲ 13×6 topics
  5. Cancer2▲ 5.9×14 topics
  6. Innate Immunity2▲ 25×3 topics
  7. Epidemiology2▲ 1.84×19 topics
  8. Dendritic Cells2▲ 77×1 topic
  9. Tumor Antigen2▲ 112×1 topic
  10. Gene Therapy2▲ 33×3 topics
  11. Vaccine2▲ 15×8 topics
  12. Reactive Oxygen Species2▲ 13×2 topics
  13. Targeted Therapy2▲ 25×4 topics
  14. Nanoparticles2▲ 4.1×4 topics
  15. Inflammation2▲ 2.4×11 topics
  16. Chemotherapy1▲ 5.8×4 topics
  17. Clinical Trials1▲ 6.2×3 topics
  18. Tumor Regression1▲ 40×2 topics
  19. Tumor Targeting1▲ 24×2 topics
  20. AAV1▲ 101×1 topic
  21. Transplant Recipients1▲ 65×2 topics
  22. Vaccine Development1▲ 15×3 topics
  23. Viral Vectors1▲ 101×1 topic
  24. Breast Cancer1▲ 15×3 topics
  25. Glycosylation1▲ 31×2 topics
  26. Infection1▲ 15×2 topics
  27. CAR T Cells1▲ 44×1 topic
  28. Chimeric Antigen Receptor1▲ 44×1 topic
  29. Congenital Infection1▲ 108×1 topic
  30. Cytomegalovirus1▲ 108×1 topic
  31. Epitope Prediction1▲ 127×1 topic
  32. Fluorescence Imaging1▲ 22×1 topic
  33. Machine Learning1◆ 0.99×3 topics
  34. Peptide-MHC Binding1▲ 127×1 topic
  35. Photothermal Therapy1▲ 26×1 topic

Which research topics does Intarcia Therapeutics (United States) publish most on?

By volume in 2022–2025: Immunotherapy and Immune Responses, Virus-based gene therapy research, vaccines and immunoinformatics approaches and CAR-T cell therapy research.

Immunotherapy and Immune Responses: 2 fractional worksVirus-based gene therapy research: 1 fractional worksvaccines and immunoinformatics approaches: 1 fractional worksCAR-T cell therapy research: 1 fractional worksCytomegalovirus and herpesvirus research: 1 fractional worksNanoplatforms for cancer theranostics: 1 fractional worksMonoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksSARS-CoV-2 and COVID-19 Research: 1 fractional worksNeutrophil, Myeloperoxid…1Neutrophil, Myeloperoxidase and Oxidative Mechanisms: 1 fractional works
ImmunologyGeneticsMolecular BiologyOncology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Immunotherapy and Immune Responses Immunology 2 works
  2. 2 Virus-based gene therapy research Genetics 1 works
  3. 3 vaccines and immunoinformatics approaches Molecular Biology 1 works
  4. 4 CAR-T cell therapy research Oncology 1 works
  5. 5 Cytomegalovirus and herpesvirus research Epidemiology 1 works
  6. 6 Nanoplatforms for cancer theranostics Biomedical Engineering 1 works
  7. 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  8. 8 Cancer Immunotherapy and Biomarkers Oncology 1 works
  9. 9 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
  10. 10 Neutrophil, Myeloperoxidase and Oxidative Mechanisms Immunology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.3%not open50.7%

World: 28% of research is openly available.

with international co-authors21.6%domestic only78.4%

World: 19% is written across borders.

How has Intarcia Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 202% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Boston

All research institutions in Boston

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.